Telecommunications Standard JULY 2012

Similar documents
National Council for Prescription Drug Programs

Upstream Reporting of Copay Assistance Issues Brief

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

NCPDP Electronic Prescribing Standards

X12N/005010X220A1Benefit Enrollment and Maintenance (834) and the X12N/005010X221A1 Health Care Claim Payment/Advice (835) QUESTIONS AND ANSWERS

Texas Vendor Drug Program Pharmacy Provider Procedure Manual

2019 Transition Policy

Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription Drug Programs (NCPDP) Version 5.

Pennsylvania PROMISe Companion Guide

E-PRESCRIBING SERVICES TERMS

Life Journey of a Claim

Best Practice Recommendation for

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

Magellan Complete Care of Virginia (MCC of VA) Provider Training. July 2017

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

NCPDP VERSION 5.1 REQUEST PAYER SHEET

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

NCPDP EMERGENCY PREPAREDNESS INFORMATION

Martin s Point Generations Advantage Policy and Procedure Form

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018

CHIPS Rules and Administrative Procedures Effective January 1, 2018

Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC Chapter 22. Pharmacy Audits

Medicare Transition POLICY AND PROCEDURES

NCPDP Version 5 Request Payer Sheet

WELCOME TO OUR OFFICE. Patient s Name: Today s Date: First Middle Last. Home Address: City: State: Zip: Telephone: Home ( ) Cellular: ( ) Work: ( )

NCPDP Update. Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard. May 23, 2017

2019 Transition Policy and Procedure

What Regulatory Requirements are Responsible for the Transactions Standards?

Enrollment Form for ENTRESTO Central Patient Support Program

PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES

Indiana Health Coverage Program Seminar Presented by MDwise Pharmacy October 22-24, 2007 P0153 (9/07)

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.

K A R A N J O HA R, M.D.

Integrated Prescription Management (IPM)/ PharmAvail Benefit Management Payor Specification Sheet

Elite Visa Benefit Card Frequently Asked Questions

**** Does the above address, match the address on your State Identification Card? Yes No *****

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]

NCPA summary of Part D Final Rule for contract year NCPA advocacy at work

Claim Revenue Optimization- Atlantic

Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions

Payer Specification Sheet For Prime Therapeutics BCBS of Texas CHIP, STAR and STAR KIDS Medicaid Programs

Claim Revenue Optimization - Ontario

Medicare Part D Transition Policy

TELECOMMUNICATION VERSION 5 QUESTIONS, ANSWERS AND EDITORIAL UPDATES

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

TELECOMMUNICATION VERSION D AND ABOVE QUESTIONS, ANSWERS AND EDITORIAL UPDATES

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers

Dr. Sarah Y. Vinson s Practice Policies

Frequently Asked Questions by Plan Members Who Require Special Authorization for Their Drugs

Ch. 358, Art. 4 LAWS of MINNESOTA for

Pharmacy Provider Enrollment Application

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

All Pharmacy Providers and Prescribing Practitioners. Subject: Significant Changes to Pharmacy Claims Processing

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward

emedny New York State Department of Health Office of Health Insurance Programs Pended Claims Report:

Braeburn Patient Assistance Program Application

Formulary Services EULA

2018 Transition Fill Policy & Procedure. Policy Title: Issue Day: Effective Dates: 01/01/2018

HOW TO REGISTER ON THE OECD ESOURCING PORTAL

Supplemental Payer Transactions (Nx) Part D Plan Nx Performance Reports Guide Effective

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.

ANTI-FRAUD PLAN INTRODUCTION

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT

Step 3: To assist us in determining the available list of pharmacy plans to be contracted, please complete the enclosed Insurance Payer List.

Prescription Drug Event (PDE) Data: Source and Processing

PEP-Portland Clinical Practices Policy Number: CP Policy Owner: Health Plan Operations Manager New Revised Reviewed

Prior Authorization between Prescribers and Processors for the Pharmacy Benefit

Archived SECTION 17 - CLAIMS DISPOSITION. Section 17 - Claims Disposition

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

Pharmacy Billing and Reimbursement

emedny Prospective Drug Utilization Review/ Electronic Claims Capture and Adjudication ProDUR/ECCA Provider Manual

AonLine Service Agreement Effective July 19, By logging into AonLine, user agrees to these terms and conditions (T&C):

Assure Card Deferred Reimbursement. Making the most of your benefits for plan members and their dependants

PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*

Compensation and Reimbursement

HIPAA Implementation: The Case for a Rational Roll-Out Plan. Released: July 19, 2004

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 572

1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0

NCPDP VERSION D CLAIM BILLING

Employers Forum of Indiana and epa. March 23, 2016

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty.

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management.

1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification.

Renee Gravalin, Partner

DEMOGRAPHICS & BILLING INFORMATION

Braeburn Access Program Probuphine (buprenorphine) Implant Patient Buy and Bill Order Form

340B Drug Program Compliance: Focus on Disproportionate Hospitals

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Coordination of Benefits. Effective Date. February 2018

PATIENT REGISTRATION FORM

2018 Medicare Part D Transition Policy

GERALD (JERRY) LEWANDOWSKI. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036

IEHP Medicare DualChoice Program Pharmacy Program Manual

Christina Agustin, MD Board Certified in Adult Psychiatry 1 Lake Bellevue Drive, Suite 101 Bellevue, WA Phone Fax:

Arizona Department of Health Services Division of Behavioral Health Services PROVIDER MANUAL NARBHA Edition

UNIVERSITY - INDUSTRY SPONSORED RESEARCH AGREEMENT

SPRINT CLOUDCOMPUTE INFRASTRUCTURE SERVICES PRODUCT ANNEX

Transcription:

Telecommunications Standard

Telecommunications Standard Copyright 2012 National Council for Prescription Drug Programs, Inc. This work is owned by National Council for Prescription Drug Programs, Inc., 9240 E. Raintree Drive, Scottsdale, AZ 85260, (480) 477-1000, ncpdp@ncpdp.org, and protected by the copyright laws of the United States. 17 U.S.C. 101, et. seq. Permission is given to Council members to copy and use the work or any part thereof in connection with the business purposes of the Council members. The work may not be changed or altered. The work may not be sold, used or exploited for commercial purposes. This permission may be revoked by National Council for Prescription Drug Programs, Inc., at any time. The National Council for Prescription Drugs Programs, Inc. is not responsible for any errors or damage as a result of the use of the work. NCPDP recognizes the confidentiality of certain information exchanged electronically through the use of its standards. Users should be familiar with the federal, state, and local laws, regulations and codes requiring confidentiality of this information and should utilize the standards accordingly. NOTICE: In addition, this NCPDP Standard contains certain data fields and elements that may be completed by users with the proprietary information of third parties. The use and distribution of third parties' proprietary information without such third parties' consent, or the execution of a license or other agreement with such third party, could subject the user to numerous legal claims. All users are encouraged to contact such third parties to determine whether such information is proprietary and if necessary, to consult with legal counsel to make arrangements for the use and distribution of such proprietary information.

TELECOMMUNICATIONS STANDARD Version n.n Table of Contents 3. BUSINESS ENVIRONMENT... 1 3.1. Objectives... 1 3.2. Participants... 1 3.2.1. Between Providers and Adjudicators... 2 iii

TELECOMMUNICATIONS STANDARD Version n.n 3 BUSINESS ENVIRONMENT 3.1 Objectives The NCPDP Telecommunication Standard Implementation Guide (Version D and above) is intended to meet two needs within the pharmacy drug claim industry: 1. to provide practical guidelines for software developers throughout the industry as they implement the Version D and above Standard, and 2. to ensure a consistent implementation of the Version D and above Standard. This version of the standard facilitates a specific type of business communication among diverse parties within the third party environment. To do this successfully, it must accomplish the following goals: Support the needs of a wide base of potential users, Maximize use of existing relevant standards wherever possible, Be flexible enough to change as needs and technology change, Be unambiguous, and Be easy to implement by carriers and vendors. 3.2 Participants The NCPDP Telecommunication Standard Implementation Guide (Version D and above) supports prescription claim transactions, services, and reportings between the following industry participants: Between Providers and Adjudicators, and Between Adjudicators (aka Payer-to-Payer) Between these entities and Switches/Intermediaries as determined by business need The NCPDP Telecommunication Standard Implementation Guide facilitates the exchange of information supporting REMS (Risk Evaluation & Mitigation Strategies) operations, PDMP (Prescription Drug Monitoring Program) reporting, and general communications between the following participants: Between Providers and REMS Administrators Between Providers and PDMP program administrators Between these entities and Switches and/or Intermediaries as determined by business need 1

Version n.n TELECOMMUNICATIONS STANDARD 3.2.1 Between Providers and Adjudicators The communication between Providers and Adjudicators is two-way and the record layout for the transmitted claim and the response to the claim are defined by the Version D and above standard. The diagram below illustrates the typical business environments in which the NCPDP Telecommunication Standard Implementation Guide (Version D and above) is employed between providers and adjudicators. Figure 3.1 - Provider/Adjudicator Participants A Provider may be a retail pharmacy, mail order pharmacy, doctor s office, clinic, hospital, long-term care facility, or any other entity, which dispenses prescription drugs and submits those prescrip tions to a payer for reimbursement. A provider may be an entity that collects and reports information about prescribing, dispensing, and consumption of dangerous or abusable drugs or products such as a grocery store or convenience store. The Adjudicator (hereinafter referred to as the Processor ) is often a third-party administrator of prescription drug programs on behalf of insurers. The Adjudicator also may be an insurer, a governmental program or any other entity, which receives prescription drug claims, makes a decision regarding the level of reimbursement to the provider, and transmits a response to the provider. An adjudicator may be an entity that receives reporting information, record keeping, auditing, or authorizations of services, such as an entity performing drug utilization review reporting or reporting related to abusable products. 2

TELECOMMUNICATIONS STANDARD Version n.n Providers may choose to transmit certain prescription drug claims to an Intermediary. Intermediaries receive claims from switches or providers, perform editing/messaging and then either pass the claims to the appropriate switch or adjudicator or return (reject) claims to the providers. The reply from the adjudicator also may pass to an intermediary for editing and messaging on its return to the provider. Providers may choose to transmit claims to an intermediary for a number of reasons, including the following: Consolidated provider reporting Inventory tracking Consolidated claim editing and messaging The Switch also receives transactions from providers and intermediaries as claims pass from providers to adjudicators. Switching companies accept transactions, optionally perform format conversions, and optionally perform pre-edits or post-edits., The switch passes the transaction to the appropriate processor. The reply from the processor also may pass through the switch on its return to the provider. (In some instances the switch returns an approved response if the transaction is for a cash prescription.) Providers utilize the services of a switch for a number of reasons, including the following: Capture of data Pre and/or post editing A processor may not support Dial-Up communications All transactions can be transmitted to one central point, the Switch Increased reliability of communications 3